|
PREVIEW-Big Human Genome lupus drug nears US market
Reuters WASHINGTON, March 7 (Reuters) – Human Genome Sciences Inc's (HGSI.O) lupus drug is poised to win US clearance this week, offering patients the first approved treatment option in a half-century and setting the company up for blockbuster … PREVIEW-Big Human Genome lupus drug nears US market Options Brief: Human Genome Sciences (HGSI) |
